2008November 4, 2008Maxygen Reports Third Quarter 2008 Financial and Business Results October 30, 2008Maxygen to Present at Rodman & Renshaw 10th Annual Healthcare Conference October 22, 2008Maxygen Announces Plans to Reduce Spending and Revise Corporate Strategy October 21, 2008Maxygen Third Quarter 2008 Financial Results Conference Call Notice September 18, 2008Maxygen and Astellas Announce Global Agreement to Develop New Therapies for Autoimmune Diseases and Transplantation August 27, 2008Maxygen Receives $3.4 Million Government Grant to Develop Vaccine Discovery Technology July 31, 2008Maxygen Reports Second Quarter 2008 Financial Results July 22, 2008Maxygen Second Quarter 2008 Financial Results Conference Call Notice July 2, 2008Bayer HealthCare and Maxygen Announce Hematology Agreement June 11, 2008Maxygen Receives Approval for Clinical Trial of Factor VIIa in the United Kingdom June 3, 2008Maxygen to Present at the Goldman Sachs 29th Annual Global Healthcare Conference May 12, 2008Maxygen to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference May 6, 2008Maxygen Reports First Quarter 2008 Financial Results April 23, 2008Maxygen First Quarter 2008 Financial Results Conference Call Notice April 21, 2008Maxygen to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference March 11, 2008Maxygen to Present at the Cowen & Company 28th Annual Health Care Conference March 4, 2008Maxygen Announces Management Changes February 12, 2008Maxygen Reports Fourth Quarter and Year End 2007 Financial Results February 11, 2008Maxygen to Present at the Roth 20th Annual OC Growth Stock Conference January 29, 2008Maxygen to Host Fourth Quarter and Year End 2007 Financial Results Conference Call on February 12, 2008 January 11, 2008Maxygen to Present at the Stanford Group Company 13th Annual Healthcare Conference January 7, 2008Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG-GCSF
Return to News
|
